搜索临床试验以:Oral potentially malignant lesions, Cathelicidin LL-37
总计24316个结果
-
Universiteit AntwerpenAbbott完全的
-
Eli Lilly and Company完全的
-
Northern California Melanoma CenterBayer; Melanoma Research Institute完全的
-
Dermatologic Cooperative Oncology Group未知治疗 | 佐剂 | III期恶性黑色素瘤 | Interferon Alpha德国
-
Novacea未知非小细胞肺癌 (NSCLC) | 雄激素非依赖性前列腺癌 (AIPC)加拿大, 美国
-
Nissan Chemical Industries完全的
-
Wyeth is now a wholly owned subsidiary of Pfizer完全的
-
University of British ColumbiaVancouver Coastal Health Research Institute; 3M完全的
-
University of ZagrebMinistry of Science, Education and Sport, Republic of Croatia完全的
-
William Beaumont HospitalsRhone-Poulenc Rorer完全的
-
University of California, San FranciscoWyeth is now a wholly owned subsidiary of Pfizer完全的
-
Hokkaido Gastrointestinal Cancer Study Group完全的
-
EZUS-LYON 1Institut National de la Santé Et de la Recherche Médicale, France; Societe Francaise de Dialyse 和其他合作者终止营养不良 | 血液透析
-
Taichung Veterans General HospitalTon General Hospital未知
-
Otsuka Beijing Research InstituteZhejiang Otsuka Pharmaceutical Co., Ltd.完全的
-
Centre Leon BerardFrench Immunotherapy Intergroup; SCAPP (Sub-Cutaneous Administration Proleukin Program)完全的
-
Hvidovre University HospitalGlostrup University Hospital, Copenhagen终止
-
UMC UtrechtDutch Health Care Insurance Board完全的
-
National Health Research Institutes, Taiwan未知
-
KGL, Inc.NYU Langone Health; Milton S. Hershey Medical Center; Allergan; State University of New York - Downstate... 和其他合作者完全的
-
Fachklinik Hornheide an der Universität Münster未知
-
Chinese University of Hong Kong未知
-
University Hospital, Angers未知
-
The University of Texas Health Science Center at...Janssen Pharmaceutica N.V., Belgium完全的